cis-Entacapone
CAS: 145195-63-7
Ref. 3D-FE22677
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
cis-Entacapone
Producto controlado
Sinónimos:
- (2Z)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide(Z)-Entacapone
- (2Z)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
- (Z)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
- (Z)-Entacapone
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2Z)-
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (Z)-
Descripción:
cis-Entacapone is a drug that is used to treat Parkinson's disease. It is a prodrug of entacapone, which is an inhibitor of catechol-O-methyltransferase (COMT), an enzyme that breaks down catecholamines such as dopamine and norepinephrine. cis-Entacapone has been shown to be effective in the treatment of Parkinson's disease when combined with levodopa, carbidopa, or benserazide. In addition, this drug has low bioavailability and poor solubility in acidic ph.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
305.29 g/mol
Fórmula:
C14H15N3O5
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
